BDNF vs GPE
Head-to-head comparison of BDNF (Brain-Derived Neurotrophic Factor (mature BDNF)) and GPE (Glycyl-L-prolyl-L-glutamic acid) — benefits, dosing, side effects, research data, and where to buy.
| Property | BDNF | GPE |
|---|---|---|
| Category | Cognitive Enhancement | Cognitive Enhancement |
| Full Name | Brain-Derived Neurotrophic Factor (mature BDNF) | Glycyl-L-prolyl-L-glutamic acid |
| Molecular Weight | 13,700 Da | 301.30 Da |
| Half-Life | minutes to hours | minutes |
| Amino Acids | 119 aa | 3 |
| Typical Dose | research-only microgram range | 0.1-10 mg/kg preclinical |
| Route | Intranasal | Intranasal/Intracerebroventricular |
| Purity | ≥98% | ≥98% |
| Studies Count | 8000 | 25 |
| Research Status | Pre-clinical | Pre-clinical |
BDNF Benefits
- ✓neurogenesis
- ✓synaptogenesis
- ✓LTP support
- ✓neuronal survival
GPE Benefits
- ✓memory consolidation
- ✓neuroprotection
- ✓synaptic plasticity
- ✓learning support
BDNF Dosing
0.1-1 µg local or intranasal research delivery|viral or protein infusion models|acute or repeated plasticity protocols
GPE Dosing
intranasal or ICV research doses|0.1-10 mg/kg preclinical range|repeat daily or intermittent protocols
BDNF Side Effects
- ⚠off-target neuroexcitation
- ⚠headache-like effects
- ⚠unknown systemic protein effects
GPE Side Effects
- ⚠limited human safety data
- ⚠short half-life
- ⚠local irritation with nasal delivery
Research Overview
BDNF
BDNF is repeatedly associated with learning, long-term potentiation, and recovery from neurologic injury in preclinical literature. Direct protein delivery is difficult, so most studies focus on pathways that raise endogenous BDNF or on localized experimental administration.
GPE
Preclinical studies suggest GPE can reduce neuronal damage and support plasticity-related pathways in the brain. Research interest centers on hippocampal function, which links it to learning and memory paradigms.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.